Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
GH Secretagogues 4 min read

CJC-1295, Ipamorelin, and Sermorelin: GHRH Analogues vs Ghrelin Receptor Agonists

Compiled & reviewed by SwissLab Analytical Chemistry & QC Team — Chromatography, Mass Spectrometry & Solubility Review Desk
Editorial Standards
Analytical Summary

A deep dive into somatotropic axis stimulation. Comparing GHRH receptor binding, DAC modification kinetics, ghrelin/GHS-R1a agonism, and pulsatile growth hormone secretion. Sermorelin is a truncated 29-amino acid native GHRH fragment (GHRH 1-29) with a short plasma half-life (~10-12 minutes).

Key Research Takeaways
  • Sermorelin is a truncated 29-amino acid native GHRH fragment (GHRH 1-29) with a short plasma half-life (~10-12 minutes).
  • CJC-1295 (Mod GRF 1-29) incorporates 4 amino acid substitutions (D-Ala2, Gln8, Ala15, Leu27) that confer dipeptidyl peptidase-4 (DPP-4) resistance.
  • CJC-1295 with DAC (Drug Affinity Complex) covalently binds serum albumin, extending terminal elimination half-life to 6-8 days.
  • Ipamorelin is a pentapeptide selective ghrelin mimetic (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that induces GH release without elevating cortisol, ACTH, or prolactin.
  • Combining CJC-1295 No DAC with Ipamorelin mimics physiological pulsatile GH release with dual-receptor synergy.
Analytical & Handling Reference Matrix
CAS Registry Number 863288-34-0 / 170851-70-4 / 86168-78-7
Molecular Formula C152H252N44O42 / C38H49N9O5 / C149H246N44O42S
Molecular Mass 3367.97 g/mol / 711.86 g/mol / 3458.17 g/mol
Primary Biological Target GHRH-R and GHS-R1a (Ghrelin Receptor)
Analytical Purity Standard ≥99.0% (RP-HPLC, C18, 214/220 nm)
Identity Verification ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%)
Lyophilized Storage -20°C desiccated, protected from UV light (24–36 months)
Reconstituted Storage 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water)

1. Receptor Differentiation: GHRH-R vs GHS-R1a

The somatotropic axis is regulated by two distinct endocrine inputs: Growth Hormone Releasing Hormone (GHRH) acting on the pituitary GHRH receptor (a Class B G-protein coupled receptor), and Ghrelin acting on the Growth Hormone Secretagogue Receptor 1a (GHS-R1a, a Class A GPCR). Sermorelin and CJC-1295 bind selectively to GHRH-R, activating adenylate cyclase and increasing intracellular cAMP. Ipamorelin selectively stimulates GHS-R1a, triggering the phospholipase C (PLC) pathway and intracellular calcium mobilization.

2. CJC-1295: Modified GRF 1-29 vs CJC-1295 with DAC

Standard Sermorelin is rapidly cleaved by plasma enzymes such as DPP-4. Modified GRF 1-29 (commonly referred to as CJC-1295 No DAC) replaces native L-Ala at position 2 with D-Ala, and modifies positions 8, 15, and 27 to resist enzymatic degradation, extending in-vitro half-life to approximately 30 minutes. CJC-1295 DAC adds a maleimidopropionic acid linker that forms a stable covalent adduct with the free cysteine-34 of endogenous albumin, transforming it into a continuous release compound that maintains elevated basal GH and IGF-1 levels over 7+ days.

3. The Selectivity Profile of Ipamorelin

Unlike earlier generation secretagogues such as GHRP-2 and GHRP-6, Ipamorelin demonstrates exceptional receptor selectivity. In competitive binding assays, Ipamorelin does not activate the 5-HT2C receptor (avoiding intense appetite stimulation) nor does it trigger the release of adrenocorticotropic hormone (ACTH), cortisol, aldosterone, or prolactin. This clean pharmacological profile makes it the benchmark selective ghrelin mimetic for laboratory investigation.

4. Reconstitution and Stability Parameters

All three peptides are lyophilized as white trifluoroacetate or acetate powders. CJC-1295 and Sermorelin dissolve readily in sterile bacteriostatic water. For prolonged stability, keep reconstituted solutions refrigerated at 2°C to 8°C. Avoid temperature cycling between freezing and thawing to prevent peptide cleavage.

5. CJC-1295 DAC vs No DAC & Ipamorelin vs Tesamorelin Receptor Kinetics

The critical structural difference between CJC-1295 with DAC (MW 3647.28 g/mol) and CJC-1295 No DAC (Mod GRF 1-29, MW 3367.97 g/mol) is the C-terminal lysine–maleimidopropionic acid (MPA) Drug Affinity Complex that covalently conjugates to Cys34 of serum albumin, extending biological half-life from ~30 minutes to 6–8 days. Comparing Ipamorelin vs Tesamorelin highlights receptor-class divergence: Ipamorelin is a selective Class A GHS-R1a pentapeptide mimetic, whereas Tesamorelin is a full-length 44-aa Class B GHRH analogue stabilized by an N-terminal trans-3-hexenoic acid group against DPP-4 proteolysis.

5. Bench Preparation & Assay Reproducibility for CJC-1295, Ipamorelin, and Sermorelin

When designing in-vitro experiments targeting GHRH-R and GHS-R1a (Ghrelin Receptor), normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (3367.97 g/mol / 711.86 g/mol / 3458.17 g/mol) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.

Peer-Reviewed References & Analytical Standards

  1. Teichman S.L. et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone. Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805. [PMID: 16352683 ↗]
  2. Raun K. et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552–561. [PMID: 9849822 ↗]
  3. Walker R.F. (2006). Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 1(4), 307–308. [PMID: 18046908 ↗]

Referenced Laboratory Research Reagents

Batch-verified SwissLab catalog entries cited in this monograph

All 66 Compounds →
Laboratory Compliance & Handling Protocol

All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.

Related Research Monographs

All monographs (44)

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog